We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.00 | 5.19% | 40.50 | 40.00 | 41.00 | 40.50 | 38.50 | 38.50 | 162,605 | 15:42:26 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 98.78 | 50.96M |
From Apr 2019 to Apr 2024
TIDMVLG
RNS Number : 3683T
Venture Life Group PLC
20 March 2019
20 March 2019
VENTURE LIFE GROUP PLC
("Venture Life" or the "Group")
Notice of Results Update
Venture Life Group plc (AIM: VLG), announces that the Company expects to announce its audited results for the year ended 31 December 2018 in early April or before. This minor delay to the original timetable is a result of the audit process taking slightly longer than planned, due principally to recent personnel changes in the Company's finance function and increased complexity arising from the implications of reporting standards, including IFRS 9 and 15. Further to the announcement on 29 January 2019, the Company continues to expect to report revenue of GBP18.7 million, a 16% increase over the prior year and for adjusted EBITDA to be at least in line with market expectations.
ENDS
For further information, please contact:
Hot Features
Premium
+44(0) 1344
Venture Life Group PLC 578004
Jerry Randall, Chief Executive Officer
+44(0)20 7397
Cenkos Securities Ltd (Nomad and Broker) 8900
Mark Connelly / Stephen Keys / Cameron MacRitchie
(Corporate Finance)
Russell Kerr / Michael Johnson (Sales)
Alma PR
Rebecca Sanders-Hewett / Hilary Buchanan / Helena +44(0)20 3405
Bogle / Jessica Joynson 0208
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market. With operations in both the UK and Italy, the Group's product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women's intimate healthcare and proctology and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples. In the UK these are supplied direct by the company, outside of the UK they are supplied by the Group's international distribution partners.
Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NORCKCDQKBKBKND
(END) Dow Jones Newswires
March 20, 2019 03:02 ET (07:02 GMT)
1 Year Venture Life Chart |
1 Month Venture Life Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
